The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesWB: Use at a concentration of 1-5 µg/ml. IHC-P: Use at a concentration of 3 µg/ml.
This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
FunctionDecoy receptor for the cytotoxic ligands TNFS14/LIGHT and TNFSF6/FASL. Protects against apoptosis.
Tissue specificityDetected in fetal lung, brain and liver. Detected in adult stomach, spinal cord, lymph node, trachea, spleen, colon and lung. Highly expressed in several primary tumors from colon, stomach, rectum, esophagus and in SW480 colon carcinoma cells.
Tumor necrosis factor receptor superfamily member 6B antibody
Tumor necrosis factor receptor superfamily member 6b decoy antibody
Anti-DcR3 antibody images
IHC-P - DcR3 antibody (ab57956)
DcR3 antibody (ab57956) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human tonsil.
Western blot - DcR3 antibody (ab57956)
Western blot against tagged recombinant protein immunogen using ab57956 DcR3 antibody at 1ug/ml. Predicted band size of immunogen is 38 kDa
References for Anti-DcR3 antibody (ab57956)
This product has been referenced in:
Zhang X et al. Protocadherin ? A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth. Mol Med Rep14:4622-4628 (2016).
Read more (PubMed: 27748813) »